By Mergers.co.uk · Last reviewed:
This guide explains how buyers commonly approach value. It is not a formal valuation, and it is not accounting, tax, legal, regulatory, clinical or employment advice. Your own advisers should advise on those matters.
In short: how is a healthcare business valued?
An established healthcare business is usually valued on sustainable EBITDA, with buyers then judging the quality of those earnings. They look at recurring and contracted income, customer or commissioner concentration, regulation and compliance, service quality, workforce stability, management depth and founder dependency. Occupancy or utilisation, property, referral sources, specialist capability, working capital, strategic fit and competitive tension between buyers can all affect the final price.
There is no universal valuation formula, and not all healthcare businesses are valued in the same way. Occupancy matters to a care home but not to a domiciliary care or staffing provider, recurring income is not always contracted income, and two businesses with similar turnover can have very different values because of their earnings quality, people, regulatory standing and cash needs.
A healthcare business is a business that provides health or care services, or services that directly support their delivery, such as residential or home care, clinics, diagnostics, therapy, specialist care, healthcare staffing or outsourced clinical services, funded privately, by commissioners or by insurers.
This guide goes deeper into valuation than our main page on selling a healthcare business, which covers the types of business we advise, buyers, sale routes and the process. For general principles across sectors, see our business valuation guide.
Why EBITDA Matters in a Healthcare Business Valuation
EBITDA (earnings before interest, tax, depreciation and amortisation) is a measure of operating profit before financing costs, tax and the write-down of assets.
Buyers usually work from maintainable EBITDA: the profit they believe the business can keep producing under normal conditions. Normalisation adjusts reported profit for owner or director remuneration that differs from a market rate, exceptional costs, non-recurring income and one-off expenditure.
Healthcare earnings are often distorted by staffing. A year with an unusually long registered manager vacancy, a temporary spike in agency cover during a recruitment gap, or a period when a unit was closed for refurbishment may understate normal profit. Equally, a period of unusually low agency spend, a one-off fee uplift or deferred maintenance may overstate it. Buyers look beyond reported EBITDA to understand what a normal year looks like, and every adjustment needs evidence that will stand up in due diligence.
Hypothetical example (made up for illustration)
A specialist care provider reports EBITDA of £1.6m. The year included £150,000 of additional agency cost while two senior nurse posts were vacant; both have since been filled permanently at a lower combined cost. It also included a £60,000 one-off backdated fee settlement from a local authority. The owner draws £50,000 where a replacement operations director would cost £110,000. A buyer might view maintainable EBITDA nearer £1.63m (£1.6m + £150,000 − £60,000 − £60,000), but would test whether the agency saving is genuinely sustainable. How each item is treated is a matter for evidence and negotiation, and your accountant should advise on the figures.
Why Revenue Quality Matters in Healthcare Valuation
Recurring income is income expected to repeat because a patient, client, service user or customer continues to use the service.
Contracted income is income supported by an agreement, subject to the actual terms of that agreement, including its duration and termination rights.
Healthcare income comes in several forms, and buyers treat them differently:
| Income type | What buyers typically consider |
|---|---|
| Contracted income | Duration, notice periods, pricing mechanism, volumes committed and renewal or re-tender dates. |
| Recurring income | How consistently it has repeated, and whether customers can stop at short notice. |
| Repeat patient, client or service-user income | Tenure, referral route and whether loyalty sits with the business or an individual practitioner. |
| Commissioner-funded income | Fee rates, fee review history, payment reliability and dependence on individual commissioners. |
| Private-pay income | Pricing power, local demand, affordability and the mix alongside funded placements or patients. |
| Framework-based work | Actual call-offs received, not the appointment alone. |
| Project or episodic income | Little forward visibility; buyers look at pipeline and repeatability. |
Historical repeat income should not automatically be described as contracted. A service user who has been with a provider for years is recurring, yet the placement may be reviewed or ended. Buyers may consider duration, notice periods, renewal history, referral sources, customer tenure, pricing, margins and concentration before deciding how much confidence to place in each stream.
Are Healthcare Businesses Valued on Revenue or EBITDA?
Established, profitable healthcare businesses are generally assessed on sustainable earnings. Revenue quality, regulation, workforce stability, customer concentration, property, growth and buyer fit then influence how a buyer views those earnings. Turnover alone is not value, occupancy alone is not value, contract revenue alone does not determine value, and EBITDA alone does not capture every quality difference between two businesses. Mergers.co.uk does not publish generic healthcare valuation multiples.
How Does Customer or Commissioner Concentration Affect Value?
Commissioner concentration is the degree to which a healthcare business depends on a small number of funders, such as local authorities, NHS bodies or insurers, for its revenue or profit.
Concentration can arise through one local authority, one NHS body or other commissioner, one insurer, one corporate customer, one referral source, one framework, or a private-pay base drawn from a narrow area. Buyers may measure it by revenue, gross profit, service location and contract, because a funder that is modest by turnover may account for a much larger share of profit, or support a single site.
Long relationships may reduce perceived risk but do not remove concentration risk: commissioning decisions, fee policies and re-tendering can change regardless of history. There is no universal threshold at which concentration becomes a problem; buyers weigh it against contract terms, margin and how embedded the service is.
How Do Occupancy and Utilisation Affect Healthcare Valuation?
These measures matter only where the business sells capacity, such as care homes, clinics, treatment centres, diagnostic facilities, specialist facilities and other capacity-based services.
Occupancy is the proportion of available beds, rooms or other relevant capacity currently in use.
Utilisation is the extent to which available clinical, operational or facility capacity is being used, based on the business's own methodology.
Buyers may assess the current level, the historic trend, seasonality, the pricing achieved at that level, capacity constraints, the staffing needed to fill more capacity, and genuine room for growth. Occupancy achieved through discounted placements, or utilisation that depends on staff working excessive hours, reads very differently from the same figure achieved at sustainable prices and staffing. Because methods differ, owners should record how each figure is calculated. We do not provide benchmark percentages.
Why Workforce Stability Matters
A healthcare business may depend on clinical staff, care staff, operational staff, registered managers where relevant, specialist practitioners and management. Recruitment and retention of these people often drive both service quality and cost, so buyers may analyse staff turnover, reliance on agency labour, vacancies, key-person dependency, management coverage across sites and shifts, and workforce cost as a share of revenue. A stable, well-supervised workforce gives a buyer more confidence that earnings will hold after completion. Employment matters are for your solicitor.
How Does Agency Labour Affect Value?
Significant agency reliance may raise cost, reduce consistency of care, compress margins and weaken operational resilience. It is not automatically negative: agency cover can be a sensible response to seasonal peaks, short vacancies or new services. A buyer will look at why it is used, whether it is temporary or structural, its cost compared with permanent staffing, trends over time and the recruitment plans in place. A falling trend backed by permanent hires is more persuasive than a promise to reduce agency use after the sale. We do not quote agency benchmarks.
Wondering how buyers will view your income and workforce?
We can help you understand how your funding mix, concentration and staffing are likely to be assessed, in confidence.
How Do Regulation and Compliance Affect Healthcare Valuation?
Regulation matters to value because it affects how reliable earnings are and how easily the business can change hands. Buyers may review regulator registration where applicable, inspection history, any conditions or restrictions, governance, policies, complaints, incidents, safeguarding processes where relevant and compliance records.
Not every healthcare business is regulated in the same way. In England, regulated activities require the relevant Care Quality Commission registration, but not every healthcare business carries on a regulated activity. Scotland, Wales and Northern Ireland have their own regulatory bodies. Changes of provider, legal entity, activities or locations may require registration changes or new registration, depending on the circumstances. The regulatory consequences of a specific transaction should be confirmed with the relevant regulator and your solicitor; our healthcare sector page and legal considerations when selling a business explain more.
Mergers.co.uk does not provide regulatory or clinical assurance.
How Do Service Quality and Reputation Affect Value?
Buyers may review evidence such as inspection outcomes where applicable, complaints and how they were resolved, incidents and what was learned, patient, client or service-user feedback, contract performance, commissioner feedback, service continuity and local reputation. No single rating works as a valuation formula. Buyers are looking for a consistent picture and evidence that the business identifies and fixes problems itself, because quality issues can affect referrals, occupancy, fee negotiations and the time and cost of integration.
How Does Property Affect a Healthcare Business Valuation?
Where the business operates from premises, buyers may consider freehold or leasehold status, lease term, rent, suitability for the service, capacity, condition, expansion potential, and whether property is owned separately from the operating company.
Property can affect transaction structure separately from the valuation of the operating business. A freehold may be sold with the company, sold separately, or retained by the owner and leased to the buyer; each changes what the buyer pays for the trading business and the rent it must then carry. A short lease, or buildings needing significant investment, may be reflected in price or terms. Mergers.co.uk does not provide property or legal advice.
How Do Referral Sources Affect Value?
Healthcare businesses may rely on commissioners, GPs, consultants, hospitals, insurers, local authorities, digital acquisition, professional referrers and repeat customers. Buyers may consider how diversified those sources are, how stable they have been, and whether referral relationships belong to the company or depend heavily on the founder or a particular practitioner. Referrals that follow an individual create a transfer risk a buyer will want to understand before completion.
Does Founder Dependency Reduce Healthcare Business Value?
Founder dependency is the extent to which a business's earnings rely on the continued involvement of its founder or a key practitioner.
In healthcare, a founder or lead practitioner may drive referrals, clinical work, key relationships, management, recruitment, reputation, service delivery and business development. Heavy dependency often affects value or structure, for example through more deferred consideration, an earn-out or a longer handover. Transferability tends to improve when relationships are institutional, management is established, procedures are documented and delivery does not rely on one individual.
Why Management Depth Matters
Buyers look for capable people in operational management, service management, registered manager roles where relevant, finance, HR, quality and compliance, and commercial management. A buyer may have more confidence in sustainable earnings where the business operates without continuous founder intervention, because the risk of performance or compliance slipping after completion is lower.
How Does Specialist Capability Affect Value?
Specialist capability can include clinical specialisms, specialist care, diagnostics, therapy, services for niche patient or service-user groups, specialist equipment, a proprietary service model or multidisciplinary teams. It can create differentiation that a buyer seeking that capability values highly. It can also create concentration risk: a narrow specialism may depend on few commissioners, scarce staff or a single referral pathway. Specialisation does not always produce a higher price; buyers will check that the capability is held by current staff and embedded in how the service runs.
Why Working Capital Matters in Healthcare M&A
Working capital is the money tied up in day-to-day trading: what customers and commissioners owe and income not yet invoiced, plus stock, less what the business owes suppliers and has received in advance.
Healthcare businesses often pay payroll, agency staff and supplies before commissioners or customers pay them. Commissioner payment terms, accrued income, delayed invoicing, stock where relevant and mobilisation costs for new contracts all affect cash. As a result, cash generation can differ from EBITDA, particularly for a business opening new services. Buyers normally agree a target level of working capital, and differences at completion are adjusted in the price. See cash in the bank when you sell and negotiating business sale deal terms. Your accountant should advise on the accounting position.
How Do Buyers Assess Growth Potential?
Buyers may look at unused capacity, additional locations, new services, new commissioner or customer relationships, pricing, recruitment capability, acquisitions and referral growth. Forecast growth is not the same as proven earnings. Growth supported by a track record, such as a recently opened service reaching planned capacity, carries more weight than a plan that depends on staff the business has not yet recruited.
Why Might Different Buyers Value the Same Healthcare Business Differently?
Each buyer sees different opportunities. Strategic value may come from:
- Geography and local density
- Specialist capability it lacks
- Customer and commissioner access
- Referral networks and cross-referral between services
- Trained clinical and care staff
- Capacity
- Property
- Service diversification
- Removing duplicated overhead
Strategic synergies do not guarantee a higher price; buyers rarely pay away the value they expect to create. A confidential process with several suitable buyers helps test this. See selling to a trade buyer.
How Might Private Equity Assess a Healthcare Business?
A private equity investor typically assesses a healthcare business as an investment it will later sell, sometimes as a platform for acquisitions. Its focus is usually on sustainable EBITDA, management, regulation and quality, workforce, recurring income, concentration, scalability, acquisition opportunities, cash generation and future exit potential. Criteria vary between funds. Some investors buy a majority and ask the founder to retain a stake, whose value then depends on how the enlarged business performs. See private equity investment and partial business sales.
Enterprise Value and What the Shareholder Actually Receives
Enterprise value is the value of the operating business as a whole, regardless of how it is financed.
Equity value is what the shareholders receive for their shares: enterprise value plus surplus cash, minus debt and debt-like items, adjusted for working capital against an agreed normal level.
In healthcare transactions, items that may need specific analysis include finance leases on equipment or vehicles, deferred income, property debt, accrued payroll and holiday pay, agency liabilities and customer deposits. Their treatment is not fixed and is agreed in negotiation.
Hypothetical example (made up for illustration)
| Item | Amount |
|---|---|
| Enterprise value agreed | £10.0m |
| Add cash in the business | + £0.9m |
| Deduct equipment finance leases | − £0.2m |
| Deduct accrued payroll and agency invoices treated as debt-like | − £0.3m |
| Deduct private-pay deposits received in advance | − £0.1m |
| Equity value before costs and tax | £10.3m |
Actual treatment depends on the deal structure and the terms agreed. The tax consequences of any sale should be discussed with a tax adviser.
What Can a Healthcare Business Owner Improve Before Going to Market?
Not every action will automatically increase value, but these usually make a healthcare business easier for buyers to assess:
- Reconcile and evidence EBITDA adjustments.
- Understand revenue by customer and commissioner.
- Analyse concentration by revenue, profit and location.
- Document contracts and funding arrangements.
- Review the workforce structure.
- Reduce excessive agency reliance where commercially practical.
- Strengthen management.
- Reduce founder dependency.
- Organise regulatory records.
- Organise inspection and quality information.
- Document complaints and incidents where relevant.
- Analyse occupancy or utilisation where relevant.
- Clarify property arrangements.
- Prepare a working-capital analysis.
- Create a clean data room.
See how to prepare a business for sale and our due diligence checklist. For the process as a whole, see sell my business and choosing business sale advisers.
Healthcare Valuation FAQs
How much is my healthcare business worth?
There is no universal formula or multiple. Value depends on maintainable EBITDA and the quality behind it: the mix of contracted, recurring and private-pay income, commissioner or customer concentration, regulatory standing, service quality, workforce stability, agency reliance, management depth, founder dependency, property, working capital and how strongly particular buyers want the business.
Are healthcare businesses valued on revenue or EBITDA?
Established, profitable healthcare businesses are generally assessed on sustainable earnings. Revenue quality, regulation, workforce stability, concentration, property, growth and buyer fit then influence how a buyer views those earnings. Turnover alone is not value, occupancy alone is not value, and EBITDA alone does not capture every quality difference.
Does recurring or contracted income increase value?
It often supports value because future earnings become easier to forecast, but it does not increase value on its own. Buyers look at contract duration, notice periods, renewal history, pricing, margins, referral sources and concentration. Recurring income is not always contracted income, and contracted income is not risk-free.
Does customer or commissioner concentration reduce value?
It can. Dependence on one local authority, NHS body, insurer, corporate customer, framework or referral source increases the risk a buyer takes on, which may affect price or deal structure. Long relationships may reduce perceived risk but do not remove it, and there is no universal threshold at which concentration becomes a problem.
How do occupancy and utilisation affect valuation?
Where they are relevant, such as in care homes, clinics or diagnostic facilities, buyers look at the current level, the historic trend, seasonality, pricing, staffing requirements and spare capacity. They are not relevant to every healthcare business, and a high figure does not create value on its own if pricing or staffing costs undermine the margin.
Does agency staff usage affect value?
It can affect cost, consistency, margins and resilience, but it is not automatically negative. A buyer will want to know why agency staff are used, whether the reliance is temporary or structural, how the cost compares with permanent staffing, how it has changed over time and what recruitment plans exist.
How does regulation affect a healthcare business sale?
Buyers may review registration where applicable, inspection history, any conditions, governance, complaints, incidents and compliance records, because these affect how reliable earnings are. Requirements differ by service and across the UK, and the regulatory consequences of a specific transaction should be confirmed with the relevant regulator and the seller's solicitor.
How important are management and workforce stability?
Very important. Healthcare services are delivered by people, so buyers look at staff turnover, vacancies, agency reliance, key-person dependency and whether managers, including registered managers where relevant, can run the business without continuous founder involvement.
How does property affect healthcare business value?
Freehold or leasehold status, lease term, rent, condition, suitability, capacity and expansion potential can all matter. Property owned separately from the operating company may be sold, leased to the buyer or retained, which can change the structure of a deal as well as the price. The owner's solicitor and property advisers should advise on the specifics.
Do I need a formal valuation before selling?
Not necessarily. A formal valuation report is not required to run a sale, and the market ultimately sets the price. An informed view of your earnings, income quality, likely buyers and issues that may affect value before going to market helps set realistic expectations and prepare.